Estimate Recalculated May 22, 2025 08:46PM EST
Gilbert H Kliman has an estimated net worth of $24.8 Million. This is based on reported shares across multiple companies, which include AVEDRO INC, TESARO, Inc., EnteroMedics Inc, Doximity, Inc., CORGENTECH INC, Invuity, Inc., Trius Therapeutics Inc, INTRALASE CORP, PMV Pharmaceuticals, Inc., GLAUKOS Corp, MACROGENICS INC, Braze, Inc., Eiger BioPharmaceuticals, Inc., Carbylan Therapeutics, Inc., STAAR SURGICAL CO, Marketo, Inc., OBALON THERAPEUTICS INC, Restoration Robotics Inc, APPLIED GENETIC TECHNOLOGIES CORP, Transcept Pharmaceuticals Inc, EPOCRATES INC, MYOGEN INC, and METABASIS THERAPEUTICS INC.
Gilbert H Kliman's CIK is 0001293171
2006 was Gilbert H Kliman's most active year for acquiring shares with 8 total transactions. Gilbert H Kliman's most active month to acquire stocks was the month of May. 2007 was Gilbert H Kliman's most active year for disposing of shares, totalling 10 transactions. Gilbert H Kliman's most active month to dispose stocks was the month of March. 2019 saw Gilbert H Kliman paying a total of $350,000.00 for 40,149 shares, this is the most they've acquired in one year. In 2022 Gilbert H Kliman cashed out on 38,076 shares for a total of $1,685,129.92, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!